Relationship between CD14-159C/T gene polymorphism and acute brucellosis risk

Mehdi Moghadampour1, Ebrahim Eskandari-Nasab2, Fatemeh Shabani3

  • 1Department of Microbiology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran; Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.

Abstract

Insights

The CD14-159C/T gene variant is linked to increased acute brucellosis risk in Iranians. The T allele and specific genotypes (CT, TT) were significantly more common in patients, suggesting a genetic predisposition.

Area of Science:

  • Genetics and Infectious Diseases
  • Immunogenetics
  • Molecular Epidemiology

Background:

  • Brucellosis is a significant zoonotic disease with varying susceptibility.
  • Genetic factors may influence an individual's risk of developing brucellosis.
  • The cluster of differentiation 14 (CD14) gene plays a role in immune response.

Purpose of the Study:

  • To examine the association between the CD14-159C/T (rs2569190) gene polymorphism and susceptibility to acute brucellosis.
  • To evaluate the role of specific CD14 genotypes and alleles in brucellosis risk within an Iranian population.

Main Methods:

  • Case-control study involving 153 Iranian brucellosis patients and 128 healthy controls.
  • Genotyping of the CD14-159C/T polymorphism was performed using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR).

Main Results:

  • The CD14-159 CT and TT genotypes were significantly associated with an increased risk of brucellosis (OR=1.993, P=0.03; OR=3.869, P=0.01, respectively).
  • The T allele was more prevalent in brucellosis patients (61%) compared to controls (45%), indicating it as a risk factor (OR=3.058, P=0.01).

Conclusions:

  • The CD14-159C/T gene polymorphism shows suggestive evidence of association with susceptibility to acute brucellosis in the Iranian population.
  • This genetic variant may contribute to the risk of developing brucellosis, warranting further investigation.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K
Probability Laws01:49

Probability Laws

Overview
44.8K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
108
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
4.3K